About the Authors
- Katsuhisa Matsuura
-
Affiliations Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo, Japan, Department of Cardiology, Tokyo Women’s Medical University, Tokyo, Japan
- Masanori Wada
-
Affiliation ABLE Corporation, Tokyo, Japan
- Kanako Konishi
-
Affiliation Asahi Kasei Co. LTD., Tokyo, Japan
- Michi Sato
-
Affiliation Asahi Kasei Co. LTD., Tokyo, Japan
- Ushio Iwamoto
-
Affiliation Asahi Kasei Co. LTD., Tokyo, Japan
- Yuko Sato
-
Affiliation Asahi Kasei Co. LTD., Tokyo, Japan
- Aki Tachibana
-
Affiliation ABLE Corporation, Tokyo, Japan
- Tetsutaro Kikuchi
-
Affiliations Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo, Japan, CellSeed Inc., Tokyo, Japan
- Takahiro Iwamiya
-
Affiliation Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo, Japan
- Tatsuya Shimizu
-
Affiliation Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo, Japan
- Jun K. Yamashita
-
Affiliation Laboratory of Stem Cell Differentiation, Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
- Masayuki Yamato
-
Affiliation Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo, Japan
- Nobuhisa Hagiwara
-
Affiliation Department of Cardiology, Tokyo Women’s Medical University, Tokyo, Japan
- Teruo Okano
-
* E-mail: tokano@abmes.twmu.ac.jp
Affiliation Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo, Japan
Competing Interests
The authors have read the journal’s policy and have the following conflicts. This research is fully granted by the Japan Society for the Promotion of Science (JSPS*) through the “Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),” initiated by the Council for Science and Technology Policy (CSTP). ABLE Corporation, Asahi Kasei Co. LTD and CellSeed Inc. have participated in the research as a collaborating institution, commissioned by the operational support institution of the research, Japan Science and Technology Agency (JST*). Although Tatsuya Shimizu and Masayuki Yamato are consultants for CellSeed, Inc., and Teruo Okano is an investor in CellSeed, Inc., this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. *JSPS is an independent administrative institution, established by way of a national law for the purpose of contributing to the advancement of science in all fields of the natural and social sciences and the humanities. *JST is an integrated organization of science and technology in Japan that establishes an infrastructure for the entire process from the creation of knowledge to the return the society.
Author Contributions
Conceived and designed the experiments: KM. Performed the experiments: KM MW MS KK UI YS AT TK TI. Analyzed the data: KM MW UI TS. Contributed reagents/materials/analysis tools: JKY. Wrote the paper: KM. Supervision: TS MY NH TO.